BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity

Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the co...

October 29, 2021 | News

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high ...

October 28, 2021 | News

Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

The announcement by WHO, comes after the approval from WHO Ethics Review Committee and relevant regulatory authorities and ethics committees of&n...

October 27, 2021 | News

Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng

The results of the study summarized this time showed that red ginseng increased the effectiveness of the vaccine, so that when red ginseng was taken togeth...

October 22, 2021 | News

Elixirgen Therapeutics Announces Licensing Agreement for Its Novel COVID-19 Vaccine

it has entered into an exclusive licensing agreement with a global pharmaceutical company (currently undisclosed) for the rights to commercialize its self-...

October 11, 2021 | News

Novavax and Serum Announce Submission to WHO for EU Listing of Novavax

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, w...

September 24, 2021 | News

DHL delivers 1 billion COVID-19 vaccine doses

• 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 since December 2020• Smooth management and execution o...

September 17, 2021 | News

Everest Medicines to Advance mRNA Vaccines in Emerging Markets in Asia

Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...

September 15, 2021 | News

Clover Biopharmaceuticals to Produce COVID-19 Vaccine

Clover Biopharmaceuticals, Ltd. (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, toda...

September 14, 2021 | News

J & J Ebola Vaccine booster shots showed strong immune responses

Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...

September 14, 2021 | News

GeneQuantum ,BrighGene to develop antibody immune agonist conjugates

GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...

September 07, 2021 | News

Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster

-Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has submitted for a conditional ...

September 06, 2021 | News

WHO SEA Region to discuss pandemic, rebuilding essential health services for UHC

The Seventy Fourth Regional Committee Session of WHO South-East Asia, the annual governing body meeting of WHO in the Region, is being hosted by Nepal from...

September 03, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

Stay Connected